DETECTION AND CHARACTERIZATION OF T-CELL LEUKEMIA VIRUS-LIKE PROVIRAL SEQUENCES IN PBLS AND TISSUES OF BABOONS BY PCR. A NEW T-CELL LEUKEMIA/LYMPHOMA TYPE I RETROVIRUS (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


DETECTION AND CHARACTERIZATION OF T-CELL LEUKEMIA VIRUS-LIKE PROVIRAL SEQUENCES IN PBLS AND TISSUES OF BABOONS BY PCR. A NEW T-CELL LEUKEMIA/LYMPHOMA TYPE I RETROVIRUS (MEETING ABSTRACT)

Fifteenth Symposium of the International Association for Comparative Research on Leukemia and Related Diseases. October 6-11, 1991, Padova/Venice, Italy, p. 86, 1991.. Unique Identifier : AIDSLINE ICDB/92682426
Schatzl H; Yakovleva L; Rose D; Inzhiia L; Lapin B; Deinhardt F; von der Helm K; Max von Pettenkofer Inst., Univ. of Munich, Munich, Germany


Abstract: The 'high lymphoma-prone' baboon stock (Papio hamadryas) of the Sukhumi Primate Center colony (USSR) is characterized by a high seroprevalence of antibodies to the STLV-I/HTLV-I type retrovirus. It is further characterized by a manifestation of nearly 80-100% of T-cell malignancies. In contrast, in other primate colonies and in wild living monkeys, at most 20% of the animals had antibodies, and only a very low incidence of T-cell lymphomas was found. One explanation for this particularity could be that, originally, the Sukhumi stock derived from a baboon which was inoculated with human lymphomatous material. To elucidate this particularity, DNA analysis of peripheral blood lymphocytes and various tissues of healthy, risked and ill Papio hamadryas baboons was performed by polymerase chain reaction (PCR). A fair correlation between serological and PCR data and symptoms of T-cell malignancy was obtained. Furthermore, the distribution of proviral DNA was investigated in different tissues. For precise identification and characterization of the Sukhumi T-cell lymphoma virus, parts of the virus genome were mapped by restriction enzyme sites and PCR-derived fragments. A 350-nucleotide fragment of the env gene revealed 52 base exchanges to HTLV-I (84% homology) and 48 to STLV-I (86% homology), including one deletion of a triplet. On the level of aa sequence, this indicated an exchange of 4 aa to STLV-I (3.4%), but only of 2 aa to HTLV-I (1.7%). Various isolates of HTLV-I are highly conserved (97-99%; also in the env region) and HTLV-I and STLV-I are homologous more than 90%; these results may indicate that the Sukhumi T-cell lymphoma virus might be a new representative of the T-cell leukemia/lymphoma virus type I family. Furthermore, the infected monkeys from Sukhumi, which develop T-cell malignancy at a high rate, might serve as a 'model' for the highly latent and prolonged pathogenesis of HTLV-I-associated T-cell leukemia/lymphoma in humans.
Keywords: Animal Chromosome Deletion Chromosome Mapping Gene Amplification Gene Products, env/GENETICS Genes, Viral/GENETICS Genome, Viral HTLV-I/*GENETICS Leukemia, T-Cell/GENETICS Lymphoma, T-Cell/*VETERINARY Monkey Diseases/*GENETICS Papio Polymerase Chain Reaction Proviruses/*GENETICS Retroviridae Infections/*GENETICS Sequence Homology, Nucleic Acid STLV/*GENETICS ABSTRACTKWDanimalchromosomedeletionchromosomemappinggeneamplificationgeneproducts,env/geneticsgenes,viral/geneticsgenome,viralhtlv-i/KWDgeneticsleukemia,t-cell/geneticslymphoma,t-cell/KWDveterinarymonkeydiseases/KWDgeneticspapiopolymerasechainreactionproviruses/KWDgeneticsretroviridaeinfections/KWDgeneticssequencehomology,nucleicacidstlv/KWDgeneticsabstract
920930
M9290914

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .